LINC02310: A Long Intergenic Non-Protein Coding RNA as a Drug Target or Biomarker

Target Name: LINC02310

NCBI ID: G105370496

LINC02310

Other Name(s): long intergenic non-protein coding RNA 2310 | Long intergenic non-protein coding RNA 2310

LINC02310: A Long Intergenic Non-Protein Coding RNA as a Drug Target or Biomarker

Introduction

LINC02310 is a long intergenic non-protein coding RNA (lncRNA) that has been identified in various studies as having potential involvement in various diseases, including cancer, neurodegenerative diseases, and mental health conditions. Its unique structure and function have made it an attractive target for further research and potentially a future drug.

Structure and Function

LINC02310 is a transcribed RNA molecule that is approximately 220 nucleotides long and has a unique 5'-end that consists of a single exon. It is located between exons 19 and 20 of human chromosome 16 and has been shown to have a higher expression level than its neighbors in the gene expression regulatory network.

LINC02310 is characterized by its ability to interact with various protein-coding RNAs, including the protein encoded by the gene SPAO2. This interaction between LINC02310 and SPAO2 has been shown to play a role in the regulation of gene expression and may be a potential drug target.

Additionally, LINC02310 has been shown to interact with the protein encoded by the gene NLRP1. This interaction may be important for the regulation of stress responses and could make LINC02310 a potential target for drugs that target stress-related diseases.

Expression and Disease

LINC02310 has been shown to be involved in various diseases and conditions, including cancer, neurodegenerative diseases, and mental health conditions. For example, studies have shown that LINC02310 is overexpressed in various cancer types, including breast, ovarian, and colorectal cancer. This overexpression is thought to contribute to the development and progression of these diseases.

In addition to its involvement in cancer, LINC02310 has also been shown to be involved in neurodegenerative diseases. Studies have shown that LINC02310 is overexpressed in various neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease. This overexpression is thought to contribute to the development and progression of these diseases.

Finally, LINC02310 has also been shown to be involved in mental health conditions. Studies have shown that LINC02310 is overexpressed in various mental health conditions, including depression and anxiety. This overexpression is thought to contribute to the development and progression of these conditions.

Drug Target Potential

The unique structure and function of LINC02310 make it an attractive target for further research and potentially a future drug. Its ability to interact with various protein-coding RNAs, including the protein encoded by the gene SPAO2, and its interaction with the protein encoded by the gene NLRP1 suggests that it may be a potential drug target for various diseases.

In addition to its potential as a drug target, LINC02310 may also be a useful biomarker for certain diseases. Its expression level is higher than that of its neighbors in the gene expression regulatory network, which suggests that it may be a more reliable indicator of disease status than other biomarkers.

Conclusion

LINC02310 is a long intergenic non-protein coding RNA that has been identified as having potential involvement in various diseases, including cancer, neurodegenerative diseases, and mental health conditions. Its unique structure and function make it an attractive target for further research and potentially a future drug. Additionally, its expression level is higher than that of its neighbors in the gene expression regulatory network, which suggests that it may be a more reliable indicator of disease status than other biomarkers. Further research is needed to fully understand the role of LINC02310 in disease and to explore its potential as a drug target or biomarker.

Protein Name: Long Intergenic Non-protein Coding RNA 2310

The "LINC02310 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC02310 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets